ADC Therapeutics SA (ADCT)
NYSE
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | |||||
Total Current Assets | |||||
Cash and Equivalents | |||||
Total Non-Current Assets | |||||
Total Liabilities | |||||
Total Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Common Equity | |||||
Retained Earnings |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 137.68M | 513.69M | 617.97M | 529.17M | 354.78M |
Total Current Assets | 122.61M | 450.45M | 525.18M | 446.02M | 336.29M |
Cash and Equivalents | 115.55M | 439.2M | 466.54M | 326.44M | 278.6M |
Total Non-Current Assets | 111.16M | 335.51M | 166.09M | 88.73M | -148.25M |
Total Liabilities | 26.53M | 178.19M | 451.88M | 440.44M | 503.03M |
Total Current Liabilities | 19.94M | 40.44M | 73.94M | 98.96M | 67.67M |
Total Non-Current Liabilities | 10.48M | 174.99M | 472.1M | 445.29M | 548.09M |
Total Equity | 111.16M | 335.51M | 166.09M | 88.73M | -148.25M |
Common Equity | 4.36M | 6.31M | 6.45M | 7.31M | 7.31M |
Retained Earnings | -448.57M | -694.86M | -924.89M | -1.08B | -1.34B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.